Clinical Trial

Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients

Study acronym: REMAP
Recruiting
View on ClinicalTrials.gov →
Summary
The REMAP study aims to follow a cohort of 400 patients in around ten sleep centers in France and to collect clinical routine data. The objectives of this study are to investigate the effects of one-year management of OSA by CPAP or MAD on sleep architecture defined by objective macro and micro sleep architecture parameters using a sleep test device. sleep connected at home, to assess the quality of sleep and the quality of life reported by patients. The study will also allow us to define predictive factors for improving sleep quality during OSA treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-06-23.
Status change: Not Yet Recruiting → Recruiting 2024-05-17
Trial Details
NCT Number NCT05435794
Lead Sponsor ResMed
Conditions OSA
Enrollment 400 participants
Start Date 2022-07-15
Primary Completion 2022-10-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2024-05-21